D. D. Monte

Metabolic activation and mechanisms of MPTP toxicity

E. Wu, Kevin P. Scotcher, D. D. Monte, 1991 .

Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration

J. Langston, A. McCormack, J. G. Atienza, 2006, Neuroscience.

Expression of D3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment

J. Langston, M. Quik, D. D. Monte, 2000, Neuroscience.

Enhanced striatal opioid receptor-mediated G-protein activation in l-dopa-treated dyskinetic monkeys

J. Langston, L. Chen, Li Chen, 2005, Neuroscience.

Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey

J. Langston, M. Quik, D. D. Monte, 2002, Neuroscience.

Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation

D. D. Di Monte, S. Krauß, P. Kahle, 2014, Cell Death and Disease.

CYP2D6 allelic frequencies in young-onset Parkinson's disease

C. Tanner, J. Langston, D. D. Di Monte, 1996, Neurology.